Onconova
![Onconova](https://www.medidata.com/wp-content/themes/md/v2/static/images/home-background.webp)
![Company Name of Partner](https://www.medidata.com/wp-content/uploads/2018/10/Onconova_company-logo.png)
Onconova Therapeutics, Inc. is a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova has three product candidates in clinical trials and several active pre-clinical programs.
Locations
- North America